NCT00362531
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
Not specified
Clinical trial condition
Glomerulonephritis
Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.
496 public trials
165 recruiting studies
Glomerulonephritis trial results
NCT00353535
- Conditions
- Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Hospital das Clinicas - Division of Urology and Radiotherapy - University of Sao Paulo São Paulo, Brazil
Completed
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
- Locations
-
- Renal Division, Peking University First Hospital Beijing, China
- Department of Nephrology, Kidney Center and key Lab of PLA, Chinese General Hospital of PLA Beijing, China
- Division of Nephrology, Nanfang Hospital, Southern Medical University Guangzhou, China
- Renal Division, the First Affiliated Hospital, Sun Yat-sen University Guangzhou, China
NCT00135967
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
- Locations
-
- Department of Nephrology Radboud University Nijmegen Medical Centre Nijmegen, Netherlands
NCT00006137
- Conditions
- Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
- Locations
-
Not specified
Completed
Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
NCT00004305
- Conditions
- Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
- Locations
-
- Ohio State University Columbus, Ohio, United States
Active, Not Recruiting
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
NCT05798117
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
- Locations
-
- Novartis Investigative Site Clayton, Victoria, Australia
- Novartis Investigative Site Paris, France
- Novartis Investigative Site Pessac, France
- Novartis Investigative Site Strasbourg, France
Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
NCT04221477
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Medical Center Birmingham, Alabama, United States
- Wallace Rheumatic Study Center Beverly Hills, California, United States
- Kaiser Permanente - Fontana Fontana, California, United States
- Kaiser Permanente - San Francisco Medical Center San Francisco, California, United States
Active, Not Recruiting
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Alabama at Birmingham - Site #336 Birmingham, Alabama, United States
- Mayo Clinic Arizona - Site #363 Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences - Site #353 Little Rock, Arkansas, United States
- Amicis Research Center - Site #341 Granada Hills, California, United States
Active, Not Recruiting
Daratumumab to Treat Active Lupus Nephritis
NCT04868838
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States